OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells remains a paramount challenge for the biopharmaceutical industry. Various strategies can be employed maximize antibody titer, including process parameter optimization, genetic engineering, and the use of perfusion technologies. Fine-tuning growth parameters